JP2002507391A - 繊維ノブのhiループに異種ペプチドエピトープを含有するアデノウイルスベクター - Google Patents
繊維ノブのhiループに異種ペプチドエピトープを含有するアデノウイルスベクターInfo
- Publication number
- JP2002507391A JP2002507391A JP2000530231A JP2000530231A JP2002507391A JP 2002507391 A JP2002507391 A JP 2002507391A JP 2000530231 A JP2000530231 A JP 2000530231A JP 2000530231 A JP2000530231 A JP 2000530231A JP 2002507391 A JP2002507391 A JP 2002507391A
- Authority
- JP
- Japan
- Prior art keywords
- fiber
- cells
- adenovirus
- gene
- knob
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7394798P | 1998-02-06 | 1998-02-06 | |
| US60/073,947 | 1998-02-06 | ||
| US9980198P | 1998-09-10 | 1998-09-10 | |
| US60/099,801 | 1998-09-10 | ||
| PCT/US1999/002549 WO1999039734A1 (en) | 1998-02-06 | 1999-02-05 | Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002507391A true JP2002507391A (ja) | 2002-03-12 |
| JP2002507391A5 JP2002507391A5 (cg-RX-API-DMAC10.html) | 2006-03-30 |
Family
ID=26755086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000530231A Pending JP2002507391A (ja) | 1998-02-06 | 1999-02-05 | 繊維ノブのhiループに異種ペプチドエピトープを含有するアデノウイルスベクター |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7297542B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1053013A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002507391A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20010034487A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1304316A (cg-RX-API-DMAC10.html) |
| AU (1) | AU744252B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9908613A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2327545A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL137681A0 (cg-RX-API-DMAC10.html) |
| NO (1) | NO20003956L (cg-RX-API-DMAC10.html) |
| WO (1) | WO1999039734A1 (cg-RX-API-DMAC10.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006514538A (ja) * | 2002-07-10 | 2006-05-11 | トランスジーン ソシエテ アノニム | 細胞受容体への結合が除去された改変アデノウイルス繊維 |
| JP2015511822A (ja) * | 2012-03-13 | 2015-04-23 | ソーク インスティテュート フォー バイオロジカル スタディーズ | アデノウイルスおよび化学二量体を用いる選択細胞の標的化 |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395875B1 (en) * | 1999-01-25 | 2002-05-28 | Brookhaven Science Associates Llc | Recombinant soluble adenovirus receptor |
| US7157266B2 (en) * | 1999-01-25 | 2007-01-02 | Brookhaven Science Associates Llc | Structure of adenovirus bound to cellular receptor car |
| CA2392272A1 (fr) * | 1999-11-25 | 2001-05-31 | Transgene S.A. | Fibre adenovirable modifiee et utilisations |
| JP5043271B2 (ja) | 2000-04-12 | 2012-10-10 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | ペプチドベースの化合物 |
| JP2003534805A (ja) | 2000-05-31 | 2003-11-25 | ユニバーシティ オブ サスカチュワン | 変化した親和性を有する改変ウシアデノウイルス |
| JP3635462B2 (ja) | 2000-05-31 | 2005-04-06 | 国立医薬品食品衛生研究所長 | アデノウイルスベクター |
| NO20004795D0 (no) | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
| CN1622830A (zh) | 2001-07-10 | 2005-06-01 | 安盛药业有限公司 | 肽基化合物 |
| EP1446479B1 (en) | 2001-09-29 | 2012-08-15 | Chae-Ok Yun | Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| US20060281090A1 (en) * | 2003-05-01 | 2006-12-14 | University Of Washington Uw Tech Transfer- Invention Licensing | Capsid-modified adenovirus vectors and methods of using the same |
| CA2524499A1 (en) * | 2003-05-14 | 2004-11-25 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Broadening adenovirus tropism |
| WO2005040333A2 (en) * | 2003-10-24 | 2005-05-06 | National Research Council Of Canada | Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| EP1720636A4 (en) | 2004-02-02 | 2012-06-20 | Univ British Columbia | SCODAPHORESIS AND METHOD AND DEVICES FOR MOVING AND CONCENTRATING PARTICLES |
| US10337054B2 (en) | 2004-02-02 | 2019-07-02 | Quantum-Si Incorporated | Enrichment of nucleic acid targets |
| US8529744B2 (en) | 2004-02-02 | 2013-09-10 | Boreal Genomics Corp. | Enrichment of nucleic acid targets |
| US9186685B2 (en) | 2012-01-13 | 2015-11-17 | The University Of British Columbia | Multiple arm apparatus and methods for separation of particles |
| US8518228B2 (en) | 2011-05-20 | 2013-08-27 | The University Of British Columbia | Systems and methods for enhanced SCODA |
| US7473418B2 (en) | 2004-03-25 | 2009-01-06 | Cell Genesys, Inc. | Pan cancer oncolytic vectors and methods of use thereof |
| DE102004021584A1 (de) * | 2004-05-03 | 2005-12-01 | Stefan Kochanek | Modifizierte virale Vektorpartikel |
| US7776322B2 (en) | 2004-08-16 | 2010-08-17 | Stefan Kochanek | Modified viral vector particles |
| CA2496294A1 (en) * | 2005-02-07 | 2006-08-07 | The University Of British Columbia | Apparatus and methods for concentrating and separating particles such as molecules |
| WO2007123737A2 (en) | 2006-03-30 | 2007-11-01 | University Of California | Methods and compositions for localized secretion of anti-ctla-4 antibodies |
| US7919079B2 (en) | 2006-03-31 | 2011-04-05 | Biosante Pharmaceuticals, Inc. | Cancer immunotherapy compositions and methods of use |
| US20100272753A1 (en) * | 2006-10-26 | 2010-10-28 | The Johns Hopkins University | Recombinant Adenovirus Vaccines |
| CA2713313A1 (en) * | 2008-02-01 | 2009-08-06 | The University Of British Columbia | Methods and apparatus for particle introduction and recovery |
| US8791239B2 (en) * | 2008-05-04 | 2014-07-29 | University Of Maryland, College Park | Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same |
| JP2012513589A (ja) | 2008-12-23 | 2012-06-14 | ジーイー・ヘルスケア・リミテッド | 骨髄イメージング剤としての99mTc−ペプチド系化合物の応用 |
| WO2010121381A1 (en) | 2009-04-21 | 2010-10-28 | The University Of British Columbia | System and methods for detection of particles |
| ES2385251B1 (es) | 2009-05-06 | 2013-05-06 | Fundació Privada Institut D'investigació Biomèdica De Bellvitge | Adenovirus oncolíticos para el tratamiento del cáncer. |
| US9458473B2 (en) * | 2010-06-29 | 2016-10-04 | The Johns Hopkins University | Compositions and methods for retargeting virus constructs |
| EP2798069B1 (en) * | 2011-12-15 | 2017-03-29 | Washington University | Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection |
| WO2013166444A2 (en) | 2012-05-04 | 2013-11-07 | Boreal Genomics Corp. | Biomarker analysis using scodaphoresis |
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| US9340835B2 (en) | 2013-03-15 | 2016-05-17 | Boreal Genomics Corp. | Method for separating homoduplexed and heteroduplexed nucleic acids |
| CN104634978A (zh) * | 2013-11-13 | 2015-05-20 | 长春百克生物科技股份公司 | 一种分型检测腺病毒中和抗体的方法以及用于分型检测腺病毒中和抗体的试剂盒 |
| US20160058889A1 (en) * | 2014-08-11 | 2016-03-03 | The Board Of Regents Of The University Of Texas System | Prevention of muscular dystrophy by crispr/cas9-mediated gene editing |
| ES2899913T3 (es) | 2014-09-24 | 2022-03-15 | Salk Inst For Biological Studi | Virus tumorales oncolíticos y métodos de uso |
| WO2016185284A1 (en) | 2015-05-20 | 2016-11-24 | Boreal Genomics, Inc. | Method for isolating target nucleic acid using heteroduplex binding proteins |
| EP3390645B1 (en) | 2016-02-23 | 2022-09-14 | Salk Institute for Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| AU2017375633C1 (en) | 2016-12-12 | 2023-04-27 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| WO2018118967A1 (en) | 2016-12-21 | 2018-06-28 | Memgen, Llc | Armed replication-competent oncolytic adenoviruses |
| SI3645551T1 (sl) | 2017-06-27 | 2024-06-28 | Regeneron Pharmaceuticals, Inc. | S tropizmi spremenjeni rekombinantni virusni vektorji in njihova uporaba za tarčni vnos genetskega materiala v človeške celice |
| BR112020019942A2 (pt) | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| US11542526B2 (en) | 2019-02-21 | 2023-01-03 | Unleash Immuno Oncolytics, Inc. | Oncolytic adenoviral vector and methods of use |
| EP4051903A1 (en) | 2019-10-29 | 2022-09-07 | Quantum-Si Incorporated | Peristaltic pumping of fluids and associated methods, systems, and devices |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
| US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US5770442A (en) * | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
| AU726544B2 (en) * | 1995-12-08 | 2000-11-09 | University Of Alabama At Birmingham Research Foundation, The | Targeted adenovirus vectors |
| EP1180932B1 (en) * | 1999-05-12 | 2012-01-11 | The Uab Research Foundation | Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
-
1999
- 1999-02-05 CN CN99804659A patent/CN1304316A/zh active Pending
- 1999-02-05 KR KR1020007008593A patent/KR20010034487A/ko not_active Withdrawn
- 1999-02-05 AU AU26595/99A patent/AU744252B2/en not_active Ceased
- 1999-02-05 BR BR9908613-1A patent/BR9908613A/pt not_active IP Right Cessation
- 1999-02-05 WO PCT/US1999/002549 patent/WO1999039734A1/en not_active Ceased
- 1999-02-05 US US09/245,603 patent/US7297542B2/en not_active Expired - Fee Related
- 1999-02-05 EP EP99906761A patent/EP1053013A4/en not_active Withdrawn
- 1999-02-05 IL IL13768199A patent/IL137681A0/xx unknown
- 1999-02-05 CA CA002327545A patent/CA2327545A1/en not_active Abandoned
- 1999-02-05 JP JP2000530231A patent/JP2002507391A/ja active Pending
-
2000
- 2000-08-04 NO NO20003956A patent/NO20003956L/no not_active Application Discontinuation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006514538A (ja) * | 2002-07-10 | 2006-05-11 | トランスジーン ソシエテ アノニム | 細胞受容体への結合が除去された改変アデノウイルス繊維 |
| JP2015511822A (ja) * | 2012-03-13 | 2015-04-23 | ソーク インスティテュート フォー バイオロジカル スタディーズ | アデノウイルスおよび化学二量体を用いる選択細胞の標的化 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20020081280A1 (en) | 2002-06-27 |
| NO20003956D0 (no) | 2000-08-04 |
| WO1999039734A1 (en) | 1999-08-12 |
| CA2327545A1 (en) | 1999-08-12 |
| CN1304316A (zh) | 2001-07-18 |
| KR20010034487A (ko) | 2001-04-25 |
| BR9908613A (pt) | 2000-10-31 |
| IL137681A0 (en) | 2001-10-31 |
| AU744252B2 (en) | 2002-02-21 |
| US7297542B2 (en) | 2007-11-20 |
| EP1053013A4 (en) | 2004-12-22 |
| AU2659599A (en) | 1999-08-23 |
| NO20003956L (no) | 2000-10-05 |
| EP1053013A1 (en) | 2000-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7297542B2 (en) | Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob | |
| JP2002507391A5 (cg-RX-API-DMAC10.html) | ||
| AU684220B2 (en) | Recombinant adenovirus comprising a chimeric penton base protein | |
| Wickham et al. | Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins | |
| AU698254B2 (en) | Chimeric adenoviral fiber protein and methods of using same | |
| EP1181382B1 (en) | Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration | |
| WO1994017832A1 (en) | Targeting and delivery of genes and antiviral agents into cells by the adenovirus penton | |
| JP2002523105A (ja) | 異種遺伝子の運搬用の標的化アデノウイルスベクター | |
| JPH11501219A (ja) | 細胞への遣伝子導入のためのベクターおよび方法 | |
| EP1002119A1 (en) | Targeted hsv vectors | |
| JP2003514526A (ja) | 永久羊膜細胞株、その生成、および遺伝子移入ベクターの生成のための使用 | |
| JP2003531609A (ja) | 目に関する形質導入用ベクターおよび遺伝子治療を目的とするその用途 | |
| JP2001503250A (ja) | 束縛ペプチドモチーフを用いたターゲッティングアデノウイルス | |
| Sharma et al. | Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model | |
| CA2317941A1 (en) | Adenoviral vectors with modified capsid proteins | |
| JP2003534805A (ja) | 変化した親和性を有する改変ウシアデノウイルス | |
| JP2007503843A (ja) | アデノウイルス親和性の拡大 | |
| EP1593742A2 (en) | Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection | |
| US6815200B1 (en) | Modified adenovirus containing a fiber replacement protein | |
| MXPA00007721A (en) | Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob | |
| NZ505950A (en) | Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob | |
| JP2003514577A (ja) | 改変アデノウイルス繊維および使用 | |
| Denby et al. | 127. Adenovirus type 5 vectors pseudotyped with fibers from subgroup D (19p and 37) show detargeting from hepatocytes in vitro and in vivo | |
| Roy et al. | 128. Use of chimeric adenoviral vectors to assess capsid neutralization determinants | |
| MXPA98004203A (en) | Vectors and methods for gene transfer acelu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060206 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060206 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081104 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090421 |